Avantax Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Avantax Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.42M	Buy	5,877 +390	+7%	+$92.2K	0.01%	973
2025 Q1	$1.34M	Buy	5,487 +1,151	+27%	+$346K	0.01%	945
2024 Q4	$1.42M	Sell	4,336 -1,365	-24%	-$463K	0.01%	883
2024 Q3	$1.91M	Sell	5,701 -4	-0.1%	-$1.27K	0.01%	719
2024 Q2	$1.56M	Buy	+5,705	New	+$1.66M	0.01%	761

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Avantax Advisory Services's BIO Position: Q2 2025 in Review

Avantax Advisory Services increased its Bio-Rad Laboratories Class A (BIO) stake by 7.1% in Q2 2025, buying an estimated $92.2K and bringing the position to 5,877 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #973.

Avantax Advisory Services first reported a position in BIO in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.91M in Q3 2024. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

Avantax Advisory Services held 5,877 shares of Bio-Rad Laboratories Class A worth $1.42M as of Q2 2025.
Avantax Advisory Services bought 390 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $92.2K.
Bio-Rad Laboratories Class A made up 0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #973 holding.
Avantax Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and has held it in 5 quarters since.
Avantax Advisory Services's Bio-Rad Laboratories Class A position peaked at $1.91M in Q3 2024.
384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.